These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22781433)

  • 1. Illuminating the diabetes-cancer link.
    Brower V
    J Natl Cancer Inst; 2012 Jul; 104(14):1048-50. PubMed ID: 22781433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes and cancer: an injurious association].
    Gariani K; Tran C; Philippe J
    Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological aspects of neoplasms in diabetes.
    Nicolucci A
    Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and pancreatic cancer: a clue requiring investigation.
    Pollak M
    Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and cancer.
    Chowdhury TA
    QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
    Herrigel DJ; Moss RA
    Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and cancer: Could vitamin D provide the link?
    Ahmad S; Chowdhury TA; Boucher BJ
    J Diabetes Complications; 2013; 27(2):184-90. PubMed ID: 23164631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer research. Cancer prevention with a diabetes pill?
    Taubes G
    Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
    [No Abstract]   [Full Text] [Related]  

  • 9. Repurposing to fight cancer: the metformin-prostate cancer connection.
    Azvolinsky A
    J Natl Cancer Inst; 2014 Feb; 106(2):dju030. PubMed ID: 24511112
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on metformin - a major cardiovascular medication. 'Diabesity - the biggest epidemic in human history'.
    Straughan JL
    Cardiovasc J Afr; 2007; 18(5):331-3. PubMed ID: 17985034
    [No Abstract]   [Full Text] [Related]  

  • 11. Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.
    Inamoto T; Shah JB; Kamat AM
    Urol Oncol; 2009; 27(6):585-91. PubMed ID: 19162510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone add-on to gliclazide and metformin on glycemic control in patients with type 2 diabetes.
    Al-Azzam SI; Alomari M; Khader YS; Almahasneh FA; Muflih SM; Altawalbeh S
    Endocr Res; 2012; 37(1):7-11. PubMed ID: 21977974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes and cancer: what is the connection?
    Cannata D; Fierz Y; Vijayakumar A; LeRoith D
    Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Background review paper on total fat, fatty acid intake and cancers.
    Gerber M
    Ann Nutr Metab; 2009; 55(1-3):140-61. PubMed ID: 19752540
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
    Kendall DM; Rubin CJ; Mohideen P; Ledeine JM; Belder R; Gross J; Norwood P; O'Mahony M; Sall K; Sloan G; Roberts A; Fiedorek FT; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1016-23. PubMed ID: 16644631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat bite: Lifetime risk of being diagnosed with cancer.
    J Natl Cancer Inst; 2003 Dec; 95(23):1745. PubMed ID: 14652235
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
    Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
    Pusceddu S; Buzzoni R; Vernieri C; Concas L; Marceglia S; Giacomelli L; Milione M; Leuzzi L; Femia D; Formisano B; Mazzaferro V; de Braud F
    Future Oncol; 2016 May; 12(10):1251-60. PubMed ID: 26890290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.